Extranodal natural killer/T-cell lymphoma, nasal type: epidemiology study
- 22 May 2012
- journal article
- Published by Springer Science and Business Media LLC in The Chinese-German Journal of Clinical Oncology
- Vol. 11 (5), 290-293
- https://doi.org/10.1007/s10330-012-0962-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A Clinical Study of 115 Patients with Extranodal Natural Killer/T-cell Lymphoma, Nasal TypeClinical Oncology, 2008
- Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisoloneAnnals of Oncology, 2008
- Extranodal NK/T‐cell lymphoma: diagnosis and treatment cuesHematological Oncology, 2008
- EBV Viral Load in Tumor Tissue Is an Important Prognostic Indicator for Nasal NK/T-Cell LymphomaAmerican Journal of Clinical Pathology, 2007
- Life‐style and environmental factors in the development of nasal NK/T‐cell lymphoma: A case–control study in East AsiaInternational Journal of Cancer, 2006
- NK/T-cell lymphomas ‘nasal type’: an Italian multicentric retrospective surveyAnnals of Oncology, 2006
- Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in SingaporeLaboratory Investigation, 2004
- Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1Pathology International, 2003
- Nasal-Type T/NK Lymphomas: A Clinicopathologic Study of 13 CasesLeukemia & Lymphoma, 2000
- Nasal and nasal-type natural killer/ T–cell lymphomaJournal of the American Academy of Dermatology, 1999